Secteur SAB Biotherapeutics, Inc.

Actions

SABS

US78397T2024

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 30/07/2026 Varia. 5j. Varia. 1 janv.
3,560 USD +2,30% Graphique intraday de SAB Biotherapeutics, Inc. -0,56% -4,81%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+2,30%-0,56%-8,72%-4,81%-4,81%+57,52%-57,69%-96,41% - 272 M
-0,81%-0,33%-0,55%+12,86%+38,44%+27,15%+81,12%-19,55% - 55,23 Md
-3,74%-6,32%-7,99%+11,77%+4,16%+42,70%+64,45%+190,17%+5 755,69% 53,75 Md
-0,11%+0,86%-0,21%-10,25%-2,47%-15,63%-13,56%-71,72% - 23,48 Md
-1,58%-5,51%-4,81%-25,56%-41,69%-3,51%+375,36%+312,56%+786,38% 22 Md
+2,96%-0,51%+8,48%+12,56%+23,73%+20,81%-11,79%-67,88% - 19,78 Md
-1,23%-3,15%+2,73%+9,11%-9,03%+26,00%-31,88%-34,96%+52,90% 17,44 Md
+0,79%-5,72%+3,64%+5,12%+23,56%+16,49%+541,43% - - 14,66 Md
+1,16%+0,58%+2,87%+25,89%+27,70%+51,87%+181,96%+232,17%+509,69% 14,07 Md
-5,09%-10,87%-15,15%+72,01%+141,92%+153,11%+272,20%+1 301,97%+585,75% 13,02 Md
-9,83%-9,25%-8,16%-4,69%-15,32%+70,11%+139,94%+464,72%+6 474,80% 11,37 Md
+1,28%+0,62%+7,13%+18,84%+31,53%+456,00%+148,56%+26,02%+1 365,10% 12,3 Md
+1,07%-5,33%-0,63%-26,29%-16,64%-39,07%+129,48%+87,28% - 10,95 Md
+2,60%-1,83%-5,60%+25,72%+26,57%+122,28%+141,86%+170,96%+623,20% 10,92 Md
+5,00%-10,28%-7,76%-37,37%-23,16%-49,59%+533,96%+83,36%+92,00% 10,72 Md
-0,30%-0,02%+123,49%+115,65%+79,66%+186,11%+345,08%+365,13% - 8,82 Md
+3,71%+1,51%+14,33%+36,33%+209,83%+487,04%+604,86%-33,77%-15,42% 8,93 Md
+3,02%-1,68%+2,19%-16,66%+13,61%+35,66%+85,28%-18,04% - 7,93 Md
-2,32%-11,93%+7,99%+23,50%+10,96%+14,78%+312,86%+320,07% - 7,69 Md
+5,62%+0,58%-3,73%-2,24%+21,28%+60,71%+19,83%+158,12% - 8,08 Md
Moyenne +0,22%-2,63%+5,48%+12,07%+26,99%+86,03%+193,17%+177,38%+1 623,01% 16,57 Md
Moyenne pondérée par Capi. -0,62%-1,39%+1,96%+10,46%+21,96%+62,92%+159,66%+152,82%+2 523,96%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action SABS
  4. Secteur SAB Biotherapeutics, Inc.